Suchergebnisse - "Mwandumba, Henry C"

PubPharm (7)

1

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Stott, K. | Ahmadu, A. | Kajanga, C. | +14

2

How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Harrison, T. | Lawrence, D. | Mwandumba, H. | +6

3

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

enthalten in: The New England journal of medicine | 2022

von Jarvis, J. | Lawrence, D. | Meya, D. | +140

CommentIn: N Engl J Med. 2022 Mar 24;386(12):1179-1181. - PMID 35320648

4

Cryptococcal meningoencephalitis : time for action

enthalten in: The Lancet. Infectious diseases | 2021

von Stott, K. | Loyse, A. | Jarvis, J. | +8

5

AMBIsome Therapy Induction OptimisatioN (AMBITION) : High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

ErratumIn: Trials. 2019 Jan 14;20(1):48. - PMID 30642386

6

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

7

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

1
[1]